GGrantIndex
← Leaderboards

Amariliz Rivera

Rutgers Biomedical And Health Sciences

$7,526,834
Attributed
$12,632,563
Total exposure
7
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.2M · FY200625
$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$12,632,563 · 7

By mechanism

R01$11,248,416 · 4
K01$636,786 · 1
R21$374,977 · 1
K22$372,384 · 1

Top collaborators

Most similar at Rutgers Biomedical And Health Sciences

Same institution · by research overlap

Others in their field

Top investigators on “Response

Research focus

ResponseMycosesInfectionPathogenImmunityCellsLungMonocyteShapesNeutrophilImmuneIn VivoInsightPublishingT-LymphocyteCessation Of LifeMediatingAffectPathway InteractionsCd4 Positive T LymphocytesAntifungal AgentsLifeAspergillosisAspergillus Fumigatus

Grant awards (33)

The role of pathogen-experienced macrophage subsets in mediating lung immunity and heterologous protection$766,391
R01 · FY2025 · AI · contact PI
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection$736,637
R01 · FY2025 · AI
Trained immunity and the regulation of anti-fungal defense$598,736
R01 · FY2025 · AI · contact PI
The role of pathogen-experienced macrophage subsets in mediating lung immunity and heterologous protection$773,368
R01 · FY2024 · AI · contact PI
Trained immunity and the regulation of anti-fungal defense$625,596
R01 · FY2024 · AI · contact PI
The role of pathogen-experienced macrophage subsets in mediating lung immunity and heterologous protection$779,547
R01 · FY2023 · AI · contact PI
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection$749,786
R01 · FY2023 · AI · contact PI
Trained immunity and the regulation of anti-fungal defense$630,799
R01 · FY2023 · AI · contact PI
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection$22,743
R01 · FY2023 · AI · contact PI
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection$749,786
R01 · FY2022 · AI · contact PI
Trained immunity and the regulation of anti-fungal defense$635,850
R01 · FY2022 · AI · contact PI
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection$71,363
R01 · FY2022 · AI · contact PI
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection$749,786
R01 · FY2021 · AI · contact PI
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection$48,620
R01 · FY2021 · AI · contact PI
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection$749,786
R01 · FY2020 · AI · contact PI
Mechanisms of vaccine protection against AIDS-associated Cryptococcus infection$749,562
R01 · FY2019 · AI · contact PI
Regulation of antifungal immunity by monocyte-derived dendritic cells$362,012
R01 · FY2019 · AI · contact PI
Regulation of antifungal immunity by monocyte-derived dendritic cells$362,012
R01 · FY2018 · AI · contact PI
Regulation of antifungal immunity by monocyte-derived dendritic cells$362,012
R01 · FY2017 · AI · contact PI
Regulation of antifungal immunity by monocyte-derived dendritic cells$362,012
R01 · FY2016 · AI · contact PI
Regulation of antifungal immunity by monocyte-derived dendritic cells$362,012
R01 · FY2015 · AI · contact PI
Role of CCR2+ monocytes and Mo-DCs in defense against IA and GVHD development$167,726
R21 · FY2014 · CA · contact PI
Role of CCR2+ monocytes and Mo-DCs in defense against IA and GVHD development$182,251
R21 · FY2013 · CA · contact PI
Role of CCR2+ monocytes and Mo-DCs in defense against IA and GVHD development$25,000
R21 · FY2013 · CA · contact PI
CD4+ T cells in Invasive Aspergillosis$149,399
K22 · FY2012 · CA · contact PI
CD4+ T cells in Invasive Aspergillosis$36,793
K22 · FY2012 · CA · contact PI
CD4+ T cells in Invasive Aspergillosis$186,192
K22 · FY2011 · CA · contact PI
Aspergillus-specific CD4+ T cells in Invasive Aspergillosis$141,399
K01 · FY2010 · CA · contact PI
Aspergillus-specific CD4+ T cells in Invasive Aspergillosis$11,304
K01 · FY2010 · CA · contact PI
Aspergillus-specific CD4+ T cells in Invasive Aspergillosis$152,703
K01 · FY2009 · CA · contact PI
Aspergillus-specific CD4+ T cells in Invasive Aspergillosis$112,778
K01 · FY2008 · CA · contact PI
Aspergillus-specific CD4+ T cells in Invasive Aspergillosis$110,438
K01 · FY2007 · CA · contact PI
Aspergillus-specific CD4+ T cells in Invasive Aspergillosis$108,164
K01 · FY2006 · CA · contact PI